Efficacy and safety of apremilast in patients with moderate-to-severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III study.
Abby S Van VoorheesL Stein GoldM LebwohlBruce E StroberHoward SofenKim A PappJ BagelZ ZhangM ParisY WangPublished in: The British journal of dermatology (2021)